FDA Approved: GLIMEPIRIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for glimepiride by Rising Pharma Holdings, Inc. to update the drug’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)